U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of Inspections and Investigations
  5. Regulatory News, Stories, and Features
  6. Public Meeting: Modernizing Recalls of FDA-Regulated Commodities - 09/29/2023
  1. Regulatory News, Stories, and Features

Meeting | Mixed

Event Title
Public Meeting: Modernizing Recalls of FDA-Regulated Commodities
September 29, 2023

Listening Session

Date:
September 29, 2023
Time:
9:00 AM - 5:00 PM ET

SUMMARY

On September 29, 2023, the U.S. Food and Drug Administration (FDA) held a free hybrid public meeting entitled “Modernizing Food and Drug Administration Recalls Listening Session.” 

This listening session provided an opportunity for stakeholders to share information and feedback about topics related to recall modernization, for FDA-regulated products. The FDA invited comments from all interested stakeholders and identified the following examples of topic categories of the type of information the agency is interested in obtaining. The FDA encouraged participants to address these topics, or any other relevant topics related to recall modernization for FDA-regulated products:

  • General recall preparations / contingency planning
  • Creating successful recall strategies, including methods to reach underserved communities
  • Initiating a recall
  • Strategies for public warning, including press releases, social media, and other communication tools
  • Increasing efficiency and effectiveness of recall information exchange
  • Ensuring effective recalls
  • Terminating a recall
  • Strategies for reducing recall recurrence for similar situations

DATE

September 29, 2023, from 9:00 a.m. – 5:00 p.m. EDT


AGENDA

KEY DEADLINES

Date Deadline(s)
October 27, 2023
(11:59 p.m. EDT)		 Deadline to submit a public comment to the docket (FDA-2023-N-2393) for this listening session.

RECORDING & TRANSCRIPT

 

A transcript of the listening session will be posted in the Event Materials section below as soon as it is available.

COMMENTING TO THE DOCKET

FDA established a public docket for this listening session. Please submit all public comments to the docket (FDA-2023-N-2393), available at Regulations.gov. The public comment period will end at 11:59 p.m. EDT on October 27, 2023

Submit an Electronic Comment

 

Back to Top